Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07443839 · ClinicalTrials.gov registry record · NA

Oncology Legal Navigation Study

A NA study of Financial Stress and Oncology Patients, sponsored by Jean Edward.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07443839: Recruiting NA study of Financial Stress and Oncology Patients, sponsored by Jean Edward.

NCT07443839 is a NA study of Financial Stress and Oncology Patients that is actively recruiting participants, run by Jean Edward. The registered enrollment target is 60 participants, below the 173-participant average among 6 other Financial Stress trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07443839, a NA study of Financial Stress and Oncology Patients, is actively recruiting participants, sponsored by Jean Edward.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related quality of life (QOL) among patients/caregivers.

Primary Outcome

Feasibility was defined as 60% or higher enrolled participant retention and resolution of financial or legal issue (based on existing oncology financial navigation studies)

Interventions

  • OTHER oncology legal navigation services

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-24
Est. Completion 2026-12-31
Phase NA
Jean Edward

4 total trials

What NCT07443839 shows while recruiting

NCT07443839 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 173-participant average among 6 other Financial Stress trials with a reported enrollment target (65% lower).

The record links to 2 conditions, with Financial Stress appearing as the primary indexed condition, and to 1 intervention - of which oncology legal navigation services is the first listed.

NCT07443839 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT07443839 about?

NCT07443839 is a clinical study titled "Oncology Legal Navigation Study". The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related ...

What is the current status of trial NCT07443839?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-24. Estimated completion is 2026-12-31.

What conditions does trial NCT07443839 study?

This clinical trial studies the following conditions: Financial Stress, Oncology Patients.

What interventions are being tested in trial NCT07443839?

The interventions under investigation include: oncology legal navigation services (OTHER).

Who is sponsoring clinical trial NCT07443839?

This trial is sponsored by Jean Edward, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07443839 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Financial Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07443839, the US trial registry maintained by the National Library of Medicine. NCT07443839 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.